naltrexone has been researched along with gamma-aminobutyric acid in 51 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (13.73) | 18.7374 |
1990's | 7 (13.73) | 18.2507 |
2000's | 15 (29.41) | 29.6817 |
2010's | 20 (39.22) | 24.3611 |
2020's | 2 (3.92) | 2.80 |
Authors | Studies |
---|---|
Moroni, F | 1 |
Cheney, DL; Costa, E; Moroni, F; Peralta, E | 2 |
Cheney, DL; Costa, E; Revuelta, AV; Wood, PL | 1 |
Jackson, HC; Nutt, DJ | 1 |
Barnes, MI; Hong, JS; Hudson, PM; Mitchell, CL | 1 |
Castellano, C; Introini-Collison, IB; McGaugh, JL; Pavone, F | 1 |
Bersh, PJ; Blustein, JE; Margules, DL; Walker, J; Whitehouse, WG | 1 |
Slater, P | 1 |
Devine, DP; Leone, P; Wise, RA | 1 |
Faden, AI; Graham, SH; Newman, A; Shimizu, H; Weinstein, P | 1 |
Mulder, AH; Ronken, E; Schoffelmeer, AN | 1 |
Borsook, D; Falkowski, O; Smirnova, O | 1 |
Faletti, AG; Gimeno, M; Lomniczi, A; Mastronardi, CA; McCann, SM; Rettori, V; Seilicovich, A | 1 |
Berntsson, A; Eirefelt, M; Söderpalm, B; Svensson, AI | 1 |
Andoh, T; Kuraishi, Y; Nojima, H; Shiraki, K; Takasaki, I | 1 |
Bodnar, RJ; Christian, G; Echo, JA; Lamonte, N; Ragnauth, A; Znamensky, V | 1 |
Chung, J; Kim, C; Kim, E; Kim, Y; Koo, G; Lee, C; Shin, M | 1 |
Auerbach, SB; Tao, R | 1 |
Chen, SR; Li, DP; Pan, HL; Pan, YZ | 1 |
Castellano, M; Cervera, G; Martínez-Raga, J; Perez-Galvez, B; Sabater, A | 1 |
Freye, E; Levy, JV; Partecke, L | 1 |
Acosta, GB; Baratti, CM; Blake, MG; Boccia, MM | 1 |
Carai, MA; Colombo, G; Gessa, GL | 1 |
Buonopane, A; Petrakis, IL | 1 |
Jung, YC; Namkoong, K | 1 |
Bernardi, M; Caputo, F; Francini, S; Stoppo, M; Vignoli, T | 1 |
Bagosi, Z; Jászberényi, M; Telegdy, G | 1 |
Andreoli, S; Bria, P; De Filippis, R; Di Giannantonio, M; Di Nicola, M; Janiri, L; Martinotti, G; Mazza, M; Moroni, N; Pomponi, M; Pozzi, G; Reina, D; Romanelli, R; Tedeschi, D | 1 |
Mabrouk, OS; Marti, M; Morari, M; Salvadori, S | 1 |
Alayan, A; Bayer, B; Dretchen, KL; Gillis, RA; Herman, MA; Sahibzada, N; Verbalis, J | 1 |
Ashenhurst, JR; Hutchison, KE; Morrow, AL; Ray, LA | 1 |
Blumell, BR; Hansen, DM; Park, JJ; Steffensen, SC; Wilcox, JD; Yang, CH; Yoon, SS | 1 |
Anton, RF; Baros, AM; Latham, PK; Myrick, H; Randall, PK; Waid, LR; Wright, TM | 1 |
O'Brien, CP | 1 |
Dicken, MS; Hentges, ST; Tooker, RE | 1 |
Coimbra, NC; da Silva, JA; de Freitas, RL; Eichenberger, GC; Padovan, CM | 1 |
Ingram, SL; Lamberts, JT; Li, MH; Neubig, RR; Smith, CE; Traynor, JR | 1 |
Bäckman, CM; Chefer, V; Counotte, DS; O'Donnell, P; Oh, E; Ramamoorthy, S; Schultz-Kuszak, KN; Shippenberg, TS; Tejeda, HA | 1 |
Kremer, AE; Mettang, T | 1 |
Ciudad, N; Lux, S; Miranda, HF; Noriega, V; Prieto, JC; Sierralta, F; Troncoso, R; Zanetta, P; Zepeda, R | 1 |
Kang-Park, M; Kieffer, BL; Moore, SD; Roberts, AJ; Siggins, GR | 1 |
Cicin-Šain, L; Kovak-Mufić, A; Marušić, S; Matošić, A; Vidrih, B | 1 |
Diaz, MR; Przybysz, KR; Werner, DF | 1 |
Lyon, J | 1 |
Alto, W; Gianutsos, P; Mancl, L; Plawman, A; Rudolf, G; Rudolf, V; Walsh, J | 1 |
Buisman-Pijlman, FT; Hutchinson, MR; Jacobsen, JHW; Mustafa, S; Rice, KC | 1 |
Guitart, J; Martinez-Escala, ME; Serrano, L; Zhou, XA | 1 |
Kayashima, S; Nagase, H; Oka, JI; Saitoh, A; Soda, A; Yamada, M; Yoshizawa, K | 1 |
Kale, PP; Marathe, PA; Pooja, SG; Raut, AA; Raut, SB; Rege, NN; Satam, SD; Shetty, YC | 1 |
Becker, C; Becker, G; Boehlke, C; Buroh, S; Coune, B; Hercz, D; Joos, L; Meerpohl, JJ; Schwarzer, G | 1 |
6 review(s) available for naltrexone and gamma-aminobutyric acid
Article | Year |
---|---|
Pharmacotherapy of alcohol use disorders.
Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Amitriptyline; Antidepressive Agents, Tricyclic; Comorbidity; Disulfiram; Dopamine; Drug Interactions; Ethanol; Female; gamma-Aminobutyric Acid; Glutamic Acid; Humans; Male; Mental Disorders; Naltrexone; Narcotics; Serotonin; Taurine | 2005 |
Pharmacotherapy for alcohol dependence: anticraving medications for relapse prevention.
Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Disulfiram; gamma-Aminobutyric Acid; Glutamine; Humans; Models, Biological; Models, Neurological; N-Methylaspartate; Naltrexone; Narcotic Antagonists; Neurons; Polymorphism, Genetic; Receptors, Opioid, mu; Recurrence; Taurine | 2006 |
Uremic pruritus.
Topics: Acupuncture Therapy; Amines; Anti-Inflammatory Agents; Calcium Channel Blockers; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; gamma-Linolenic Acid; Humans; Morphinans; Naltrexone; Narcotic Antagonists; Pentoxifylline; Phototherapy; Pregabalin; Pruritus; Receptors, Opioid, kappa; Renal Insufficiency, Chronic; Spiro Compounds; Tacrolimus; Thalidomide; Uremia | 2015 |
NEUROBIOLOGICAL BASES OF ALCOHOL ADDICTION.
Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Brain; Disulfiram; Dopamine; gamma-Aminobutyric Acid; Glutamic Acid; Humans; Minisatellite Repeats; Monoamine Oxidase; Naltrexone; Narcotic Antagonists; Neuropeptide Y; Norepinephrine; Ondansetron; Polymorphism, Genetic; Serotonin; Synaptic Transmission; Taurine | 2016 |
Pruritus in Cutaneous T-Cell Lymphoma and Its Management.
Topics: Adrenal Cortex Hormones; Amines; Antidepressive Agents, Tricyclic; Antipruritics; Cyclohexanecarboxylic Acids; Emollients; Gabapentin; gamma-Aminobutyric Acid; Histamine Antagonists; Humans; Lymphoma, T-Cell, Cutaneous; Naltrexone; Narcotic Antagonists; Neurokinin-1 Receptor Antagonists; Pruritus; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Surveys and Questionnaires; Visual Analog Scale | 2018 |
Pharmacological interventions for pruritus in adult palliative care patients.
Topics: Animals; Capsaicin; Cromolyn Sodium; gamma-Aminobutyric Acid; Humans; Naltrexone; Ondansetron; Palliative Care; Paroxetine; Receptors, Opioid; Rifampin; Zinc Sulfate | 2023 |
5 trial(s) available for naltrexone and gamma-aminobutyric acid
Article | Year |
---|---|
Add-on gabapentin in the treatment of opiate withdrawal.
Topics: Acetates; Adult; Amines; Cyclohexanecarboxylic Acids; Excitatory Amino Acid Antagonists; Female; Gabapentin; gamma-Aminobutyric Acid; Heroin; Heroin Dependence; Humans; Male; Naltrexone; Narcotic Antagonists; Narcotics; Recurrence; Substance Withdrawal Syndrome | 2004 |
Use of gabapentin for attenuation of symptoms following rapid opiate detoxification (ROD)--correlation with neurophysiological parameters--.
Topics: Acetates; Adult; Amines; Anesthesia; Anesthetics, Intravenous; Cyclohexanecarboxylic Acids; Electric Stimulation; Evoked Potentials, Somatosensory; Excitatory Amino Acid Antagonists; Female; Gabapentin; gamma-Aminobutyric Acid; Heroin Dependence; Hormone Antagonists; Humans; Magnesium; Male; Median Nerve; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Potassium; Propofol; Restless Legs Syndrome; Somatostatin; Substance Withdrawal Syndrome; Water-Electrolyte Balance | 2004 |
Pregabalin versus naltrexone in alcohol dependence: a randomised, double-blind, comparison trial.
Topics: Adult; Alcohol Withdrawal Delirium; Alcohol-Related Disorders; Anticonvulsants; Anxiety; Calcium Channel Blockers; Double-Blind Method; Female; gamma-Aminobutyric Acid; Hostility; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Obsessive-Compulsive Disorder; Pregabalin; Severity of Illness Index; Substance Withdrawal Syndrome | 2010 |
Naltrexone selectively elevates GABAergic neuroactive steroid levels in heavy drinkers with the Asp40 allele of the OPRM1 gene: a pilot investigation.
Topics: Adult; Alcohol Drinking; Alcoholism; Alleles; Amino Acid Substitution; Aspartic Acid; Double-Blind Method; Female; gamma-Aminobutyric Acid; Humans; Male; Naltrexone; Pilot Projects; Polymorphism, Single Nucleotide; Pregnanolone; Receptors, Opioid, mu; Young Adult | 2010 |
Gabapentin combined with naltrexone for the treatment of alcohol dependence.
Topics: Adult; Alcohol Drinking; Alcoholism; Amines; Cyclohexanecarboxylic Acids; Drug Administration Schedule; Drug Therapy, Combination; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Secondary Prevention; Substance Withdrawal Syndrome; Treatment Outcome | 2011 |
40 other study(ies) available for naltrexone and gamma-aminobutyric acid
Article | Year |
---|---|
GABA turnover as a tool to explore the function of GABA-ergic synapses: physiological and pharmacological studies.
Topics: Animals; Brain; Carbon Isotopes; Electric Stimulation; gamma-Aminobutyric Acid; Homovanillic Acid; Kinetics; Morphine; Naltrexone; Neurotransmitter Agents; Rats; Substantia Nigra; Synapses; Tissue Distribution | 1979 |
Opiate receptor agonists as modulators of gamma-aminobutyric acid turnover in the nucleus caudatus, globus pallidus and substantia nigra of the rat.
Topics: Animals; Catalepsy; Caudate Nucleus; Endorphins; gamma-Aminobutyric Acid; Globus Pallidus; Humans; Male; Morphine; Muscimol; Naltrexone; Rats; Receptors, Opioid; Substantia Nigra | 1978 |
GABAergic mediation in the inhibition of hippocampal acetylcholine turnover rate elicited by delta 9-tetrahydrocannabinol.
Topics: Acetylcholine; Animals; Bicuculline; Dopamine; Dronabinol; gamma-Aminobutyric Acid; Hippocampus; Kinetics; Male; Muscimol; Naltrexone; Norepinephrine; Rats; Substantia Nigra | 1979 |
On the regulation of gamma-aminobutyric acid neurons in caudatus, pallidus and nigra: effects of opioids and dopamine agonists.
Topics: Animals; Apomorphine; Brain; Caudate Nucleus; Corpus Striatum; Decerebrate State; Dopamine; Endorphins; gamma-Aminobutyric Acid; Globus Pallidus; Male; Morphine; Naltrexone; Narcotics; Neurons; Rats; Substantia Nigra | 1979 |
Differential effects of selective mu-, kappa- and delta-opioid antagonists on electroshock seizure threshold in mice.
Topics: Animals; Anticonvulsants; Bicuculline; Dose-Response Relationship, Drug; Electroshock; gamma-Aminobutyric Acid; Indoles; Male; Mice; Mice, Inbred Strains; Morphinans; Naloxone; Naltrexone; Narcotic Antagonists; Phenytoin; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu | 1991 |
Opioid mu and delta receptor antagonists reduce wet dog shaking elicited by perforant path stimulation.
Topics: Animals; Dynorphins; Electric Stimulation; Enkephalin, Leucine; Enkephalin, Methionine; gamma-Aminobutyric Acid; Hippocampus; Male; Naltrexone; Peptide Fragments; Rats; Rats, Inbred F344; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, mu; Stereotyped Behavior | 1991 |
Effects of naloxone and naltrexone on memory consolidation in CD1 mice: involvement of GABAergic mechanisms.
Topics: Animals; Avoidance Learning; Bicuculline; gamma-Aminobutyric Acid; Male; Memory; Mice; Mice, Inbred Strains; Muscimol; Naloxone; Naltrexone; Picrotoxin | 1989 |
Shock controllability and opioid substrates of escape performance and nociception: differential effects of peripherally and centrally acting naltrexone.
Topics: Animals; Brain; Endorphins; Escape Reaction; gamma-Aminobutyric Acid; Male; Naltrexone; Nervous System; Pain; Peripheral Nerves; Pituitary Gland; Rats; Reaction Time; Stress, Physiological | 1985 |
Pharmacological profile of wet-dog shaking induced by electrical stimulation of the fornix in rats.
Topics: Adenosine; Aminooxyacetic Acid; Animals; Atropine; Behavior, Animal; Dopamine; Electric Stimulation; Electrodes, Implanted; Female; gamma-Aminobutyric Acid; Injections, Intraventricular; Limbic System; Naloxone; Naltrexone; Neural Pathways; Physostigmine; Picrotoxin; Propranolol; Rats; Rats, Inbred Strains; Serotonin | 1984 |
Mesolimbic dopamine neurotransmission is increased by administration of mu-opioid receptor antagonists.
Topics: Amino Acid Sequence; Animals; Dopamine; gamma-Aminobutyric Acid; Injections, Intraventricular; Male; Microdialysis; Molecular Sequence Data; Naltrexone; Narcotic Antagonists; Nucleus Accumbens; Rats; Rats, Inbred Strains; Receptors, Opioid, mu; Somatostatin; Ventral Tegmental Area | 1993 |
Opioid receptor antagonist nalmefene stereospecifically inhibits glutamate release during global cerebral ischemia.
Topics: Animals; Aspartic Acid; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; gamma-Aminobutyric Acid; Glutamates; Glutamic Acid; Glycine; Hippocampus; Ischemic Attack, Transient; Kinetics; Male; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Reperfusion; Stereoisomerism; Taurine; Time Factors | 1993 |
Interacting presynaptic kappa-opioid and GABAA receptors modulate dopamine release from rat striatal synaptosomes.
Topics: Analysis of Variance; Animals; Benzeneacetamides; Bicuculline; Corpus Striatum; Dopamine; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; gamma-Aminobutyric Acid; Kinetics; Male; Naltrexone; Narcotics; Oligopeptides; Picrotoxin; Potassium; Pyrrolidines; Rats; Rats, Wistar; Receptors, GABA-A; Receptors, Opioid, kappa; Synaptosomes | 1993 |
Proenkephalin gene regulation in the paraventricular nucleus by GABA: interactions with opioid systems in a transgenic model.
Topics: Aminooxyacetic Acid; Animals; beta-Galactosidase; Cells, Cultured; Enkephalins; GABA-A Receptor Agonists; gamma-Aminobutyric Acid; Gene Expression Regulation; Humans; Hypothalamus; Mice; Mice, Transgenic; Muscimol; Naltrexone; Narcotic Antagonists; Organ Culture Techniques; Paraventricular Hypothalamic Nucleus; Protein Precursors; Recombinant Fusion Proteins; Saline Solution, Hypertonic; Stress, Physiological | 1998 |
beta-Endorphin blocks luteinizing hormone-releasing hormone release by inhibiting the nitricoxidergic pathway controlling its release.
Topics: Animals; beta-Endorphin; Dinoprostone; gamma-Aminobutyric Acid; Gonadotropin-Releasing Hormone; Hypothalamo-Hypophyseal System; Hypothalamus, Middle; Kinetics; Male; Models, Neurological; Naltrexone; Neurons; Nitric Oxide; Nitric Oxide Synthase; Organ Culture Techniques; Phentolamine; Rats; Rats, Wistar; Receptors, Opioid, mu | 1999 |
Naloxone antagonizes GABA(A)/benzodiazepine receptor function in rat corticohippocampal synaptoneurosomes.
Topics: Amobarbital; Animals; Cerebral Cortex; Chlorine; GABA Modulators; GABA-A Receptor Antagonists; gamma-Aminobutyric Acid; Hippocampus; Male; Morphine; Naloxone; Naltrexone; Narcotic Antagonists; Narcotics; Neurons; Radioisotopes; Rats; Rats, Sprague-Dawley; Synaptosomes | 2000 |
Gabapentin antinociception in mice with acute herpetic pain induced by herpes simplex virus infection.
Topics: Acetates; Amines; Analgesics; Animals; Behavior, Animal; Cyclohexanecarboxylic Acids; Drug Tolerance; Female; Gabapentin; gamma-Aminobutyric Acid; Herpes Simplex; Herpesvirus 1, Human; Hyperalgesia; Mice; Mice, Inbred BALB C; Motor Activity; Naltrexone; Narcotic Antagonists; Pain | 2001 |
gamma-Aminobutyric acid receptor subtype antagonists differentially alter opioid-induced feeding in the shell region of the nucleus accumbens in rats.
Topics: Animals; Baclofen; Bicuculline; Eating; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; GABA Agonists; GABA Antagonists; GABA-A Receptor Antagonists; GABA-B Receptor Antagonists; gamma-Aminobutyric Acid; Male; Naltrexone; Narcotic Antagonists; Narcotics; Neurons; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Receptors, GABA; Receptors, GABA-A; Receptors, GABA-B; Receptors, Opioid | 2001 |
Modulation of Chelidonii herba on GABA activated chloride current in rat PAG neurons.
Topics: Animals; Bicuculline; Chelidonium; Chloride Channels; Female; GABA Antagonists; gamma-Aminobutyric Acid; Male; Naltrexone; Narcotic Antagonists; Neurons; Patch-Clamp Techniques; Periaqueductal Gray; Plant Preparations; Rats; Rats, Sprague-Dawley | 2001 |
GABAergic and glutamatergic afferents in the dorsal raphe nucleus mediate morphine-induced increases in serotonin efflux in the rat central nervous system.
Topics: Analgesics, Opioid; Animals; Central Nervous System; Excitatory Amino Acid Agonists; GABA Agonists; GABA-A Receptor Agonists; gamma-Aminobutyric Acid; Glutamic Acid; Male; Microdialysis; Microinjections; Morphine; Muscimol; Naltrexone; Narcotic Antagonists; Neurons, Afferent; Nucleus Accumbens; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Receptors, Glutamate; Serotonin | 2002 |
Activation of delta-opioid receptors excites spinally projecting locus coeruleus neurons through inhibition of GABAergic inputs.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Analgesics, Opioid; Animals; Bicuculline; Dopamine beta-Hydroxylase; Electrophysiology; Enkephalin, D-Penicillamine (2,5)-; Excitatory Postsynaptic Potentials; GABA Antagonists; gamma-Aminobutyric Acid; Immunohistochemistry; Locus Coeruleus; Naltrexone; Narcotic Antagonists; Neural Pathways; Neurons; Presynaptic Terminals; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Spinal Cord | 2002 |
Posttraining administration of pentylenetetrazol dissociates gabapentin effects on memory consolidation from that on memory retrieval process in mice.
Topics: Amines; Animals; Anticonvulsants; Avoidance Learning; Behavior, Animal; Convulsants; Cyclohexanecarboxylic Acids; Dose-Response Relationship, Drug; Drug Interactions; Gabapentin; gamma-Aminobutyric Acid; Male; Memory; Mice; Mice, Inbred Strains; Naltrexone; Narcotic Antagonists; Pentylenetetrazole; Reaction Time; Retention, Psychology; Time Factors | 2004 |
Resuscitative effect of a gamma-aminobutyric acid B receptor antagonist on gamma-hydroxybutyric acid mortality in mice.
Topics: Animals; Benzocycloheptenes; Bicuculline; Drug Overdose; Flumazenil; GABA Antagonists; gamma-Aminobutyric Acid; Male; Mice; Morpholines; Naltrexone; Neuroprotective Agents; Neurotransmitter Agents; Survival Rate; Taurine | 2005 |
GABAergic medications for treating alcohol dependence.
Topics: Alcoholism; Baclofen; Drug Therapy, Combination; GABA Agonists; gamma-Aminobutyric Acid; Humans; Hydroxybutyrates; Naltrexone; Narcotic Antagonists; Randomized Controlled Trials as Topic; Receptors, GABA-B; Substance Withdrawal Syndrome; Temperance | 2007 |
The effects of endomorphins on striatal [3H]GABA release induced by electrical stimulation: an in vitro superfusion study in rats.
Topics: Animals; Corpus Striatum; Dipeptidyl-Peptidase IV Inhibitors; Electric Stimulation; gamma-Aminobutyric Acid; Male; Naloxone; Naltrexone; Oligopeptides; Perfusion; Rats; Rats, Wistar; Receptors, Opioid, mu; Tritium | 2009 |
The novel delta opioid receptor agonist UFP-512 dually modulates motor activity in hemiparkinsonian rats via control of the nigro-thalamic pathway.
Topics: Amino Acids; Animals; Antiparkinson Agents; Benzimidazoles; Dose-Response Relationship, Drug; gamma-Aminobutyric Acid; Globus Pallidus; Glutamic Acid; Male; Motor Activity; Naltrexone; Narcotic Antagonists; Neural Pathways; Oligopeptides; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Substantia Nigra; Thalamus | 2009 |
micro-Opioid receptor stimulation in the medial subnucleus of the tractus solitarius inhibits gastric tone and motility by reducing local GABA activity.
Topics: Animals; Down-Regulation; Efferent Pathways; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; GABA Antagonists; GABA-A Receptor Antagonists; gamma-Aminobutyric Acid; Gastric Fundus; Gastrointestinal Motility; Male; Microinjections; Muscle Tonus; Naltrexone; Narcotic Antagonists; Neurotransmitter Agents; Oligopeptides; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Receptors, Opioid; Solitary Nucleus; Stomach; Vagus Nerve | 2010 |
Acupuncture inhibits GABA neuron activity in the ventral tegmental area and reduces ethanol self-administration.
Topics: Action Potentials; Acupuncture Therapy; Animals; Drug Interactions; Electric Stimulation; Ethanol; gamma-Aminobutyric Acid; Male; Naloxone; Naltrexone; Neurons; Rats; Rats, Wistar; Self Administration; Sucrose; Tail; Ventral Tegmental Area | 2010 |
Adapting treatment to patient problems.
Topics: Alcoholism; Amines; Cyclohexanecarboxylic Acids; Drug Administration Schedule; Drug Therapy, Combination; Gabapentin; gamma-Aminobutyric Acid; Humans; Naltrexone; Research Design; Sertraline | 2011 |
Regulation of GABA and glutamate release from proopiomelanocortin neuron terminals in intact hypothalamic networks.
Topics: Adrenocorticotropic Hormone; Analgesics, Opioid; Animals; Channelrhodopsins; Excitatory Postsynaptic Potentials; Female; gamma-Aminobutyric Acid; Glutamic Acid; Hypothalamus; In Vitro Techniques; Inhibitory Postsynaptic Potentials; Light; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Naltrexone; Narcotic Antagonists; Nerve Net; Neurons; Neurotransmitter Agents; Patch-Clamp Techniques; Peptides; Presynaptic Terminals; Pro-Opiomelanocortin; Quinoxalines | 2012 |
Chemical neuroanatomical and psychopharmacological evidence that κ receptor-mediated endogenous opioid peptide neurotransmission in the dorsal and ventral mesencephalon modulates panic-like behaviour.
Topics: Animals; Electric Stimulation; gamma-Aminobutyric Acid; Instinct; Male; Mesencephalon; Naltrexone; Neuroanatomy; Neurons; Opioid Peptides; Panic; Psychopharmacology; Rats; Rats, Wistar; Receptors, Opioid, kappa; Substantia Nigra; Synaptic Transmission | 2013 |
Differential control of opioid antinociception to thermal stimuli in a knock-in mouse expressing regulator of G-protein signaling-insensitive Gαo protein.
Topics: Analgesics, Opioid; Animals; Brain; Diprenorphine; Dose-Response Relationship, Drug; Electric Stimulation; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Excitatory Amino Acid Antagonists; Female; GABA Antagonists; gamma-Aminobutyric Acid; Gene Expression Regulation; GTP-Binding Protein alpha Subunits, Gi-Go; Guanosine 5'-O-(3-Thiotriphosphate); Hot Temperature; Humans; Hyperalgesia; Inhibitory Postsynaptic Potentials; Isotopes; Male; Methadone; Mice; Mice, Transgenic; Morphine; Mutation; Naloxone; Naltrexone; Narcotic Antagonists; Neurons; Oligopeptides; Pain Measurement; Patch-Clamp Techniques; Pertussis Toxin; Protein Binding; Reaction Time; RGS Proteins; Signal Transduction; Spinal Cord | 2013 |
Prefrontal cortical kappa-opioid receptor modulation of local neurotransmission and conditioned place aversion.
Topics: Analgesics; Animals; Avoidance Learning; Benzeneacetamides; Dicarboxylic Acids; Dopamine; Drug Interactions; Excitatory Postsynaptic Potentials; gamma-Aminobutyric Acid; Glutamic Acid; Male; Mice; Mice, Knockout; Microinjections; Miniature Postsynaptic Potentials; Naltrexone; Narcotic Antagonists; Neurotransmitter Uptake Inhibitors; Prefrontal Cortex; Pyramidal Cells; Pyrrolidines; Rats; Receptors, Opioid, kappa; Synaptic Transmission | 2013 |
Involvement of nitridergic and opioidergic pathways in the antinociception of gabapentin in the orofacial formalin test in mice.
Topics: Amines; Analgesics; Animals; Cyclohexanecarboxylic Acids; Dose-Response Relationship, Drug; Gabapentin; gamma-Aminobutyric Acid; Male; Mice; Naltrexone; Narcotic Antagonists; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Pain Measurement; Signal Transduction | 2015 |
Interaction of CRF and kappa opioid systems on GABAergic neurotransmission in the mouse central amygdala.
Topics: Animals; Central Amygdaloid Nucleus; Corticotropin-Releasing Hormone; gamma-Aminobutyric Acid; Inhibitory Postsynaptic Potentials; Mice, Inbred C57BL; Mice, Knockout; Miniature Postsynaptic Potentials; Naltrexone; Receptors, Corticotropin-Releasing Hormone; Receptors, Opioid, kappa; Synaptic Transmission | 2015 |
Age-dependent regulation of GABA transmission by kappa opioid receptors in the basolateral amygdala of Sprague-Dawley rats.
Topics: Aging; Animals; Basolateral Nuclear Complex; Benzeneacetamides; gamma-Aminobutyric Acid; Glutamic Acid; Inhibitory Postsynaptic Potentials; Male; Naltrexone; Pyrrolidines; Rats; Receptors, Opioid, kappa; Synaptic Transmission | 2017 |
More Treatments on Deck for Alcohol Use Disorder.
Topics: Acamprosate; Alcohol Deterrents; Alcohol-Related Disorders; Amines; Baclofen; Cyclohexanecarboxylic Acids; Cytidine Diphosphate Choline; Disulfiram; Drug Repositioning; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Mifepristone; Naltrexone; National Institute on Alcohol Abuse and Alcoholism (U.S.); Off-Label Use; Patient Acceptance of Health Care; Taurine; Topiramate; United States; Varenicline | 2017 |
A novel non-opioid protocol for medically supervised opioid withdrawal and transition to antagonist treatment.
Topics: Adult; Amines; Analgesics, Opioid; Buprenorphine; Clonidine; Counseling; Cyclohexanecarboxylic Acids; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Hydroxyzine; Male; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Retrospective Studies; Substance Withdrawal Syndrome; Treatment Outcome; Young Adult | 2018 |
Antagonising TLR4-TRIF signalling before or after a low-dose alcohol binge during adolescence prevents alcohol drinking but not seeking behaviour in adulthood.
Topics: Adaptor Proteins, Vesicular Transport; Animals; Animals, Newborn; Binge Drinking; Central Nervous System Depressants; Dose-Response Relationship, Drug; Drug-Seeking Behavior; Ethanol; Female; gamma-Aminobutyric Acid; Mice; Mice, Inbred BALB C; Naltrexone; Pregnancy; RNA, Messenger; Signal Transduction; Toll-Like Receptor 4 | 2018 |
A delta opioid receptor agonist, KNT-127, in the prelimbic medial prefrontal cortex attenuates glial glutamate transporter blocker-induced anxiety-like behavior in mice.
Topics: Amino Acid Transport System X-AG; Animals; Anti-Anxiety Agents; Anxiety; Aspartic Acid; Drug Interactions; gamma-Aminobutyric Acid; Glutamic Acid; Male; Mice; Microinjections; Morphinans; Naltrexone; Prefrontal Cortex; Receptors, Opioid, delta | 2018 |
Effect of Withania somnifera (L.) Dunal aqueous root extract on reinstatement using conditioned place preference and brain GABA and dopamine levels in alcohol dependent animals.
Topics: Alcoholism; Animals; Behavior, Animal; Brain; Disease Models, Animal; Dopamine; Female; gamma-Aminobutyric Acid; Male; Medicine, Ayurvedic; Mice; Naltrexone; Plant Extracts; Plant Roots; Rats, Wistar; Withania | 2021 |